Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jarva

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Ocular Immunology and Inflammation|December 10, 2008
Complement activation in tear fluid during occupational mold challengeS Peltonen, O Kari, H Jarva, et al.
Journal of Virological Methods|January 20, 2022
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infectionM J Ahava, S Kurkela, S Kuivanen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1S Junnikkala, T S Jokiranta, M A Friese, et al.
Scandinavian Journal of Immunology|March 1, 2011
Defective central tolerance in Aire-deficient mice is not sufficient to induce symptomatic autoimmunity during lymphopenia-induced T cell proliferationE Kekäläinen, M-K Lehto, E Smeds, et al.
British Journal of Cancer|October 29, 2002
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cellsS Junnikkala, J Hakulinen, H Jarva, et al.
British Journal of Cancer|February 24, 2005
Ascitic complement system in ovarian cancerL Bjørge, J Hakulinen, O K Vintermyr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2001
Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infectionsM Seppänen, M L Lokki, T Timonen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 21, 2020
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisationA J Jääskeläinen, S Kuivanen, E Kekäläinen, et al.
Clinical and Experimental Immunology|August 2, 2006
Immunoglobulins and complement factor C4 in adult rhinosinusitisM Seppänen, J Suvilehto, M-L Lokki, et al.
Infectious Diseases (London, England)|October 28, 2022
Low incidence of severe bacterial infections in hospitalised patients with COVID-19: A population-based registry studyM J Ahava, E Kortela, E Forsblom, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Ocular Immunology and Inflammation|December 10, 2008
Complement activation in tear fluid during occupational mold challengeS Peltonen, O Kari, H Jarva, et al.
Journal of Virological Methods|January 20, 2022
Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infectionM J Ahava, S Kurkela, S Kuivanen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2000
Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1S Junnikkala, T S Jokiranta, M A Friese, et al.
Scandinavian Journal of Immunology|March 1, 2011
Defective central tolerance in Aire-deficient mice is not sufficient to induce symptomatic autoimmunity during lymphopenia-induced T cell proliferationE Kekäläinen, M-K Lehto, E Smeds, et al.
British Journal of Cancer|October 29, 2002
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cellsS Junnikkala, J Hakulinen, H Jarva, et al.
British Journal of Cancer|February 24, 2005
Ascitic complement system in ovarian cancerL Bjørge, J Hakulinen, O K Vintermyr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2001
Complement C4 deficiency and HLA homozygosity in patients with frequent intraoral herpes simplex virus type 1 infectionsM Seppänen, M L Lokki, T Timonen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 21, 2020
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisationA J Jääskeläinen, S Kuivanen, E Kekäläinen, et al.
Clinical and Experimental Immunology|August 2, 2006
Immunoglobulins and complement factor C4 in adult rhinosinusitisM Seppänen, J Suvilehto, M-L Lokki, et al.
Infectious Diseases (London, England)|October 28, 2022
Low incidence of severe bacterial infections in hospitalised patients with COVID-19: A population-based registry studyM J Ahava, E Kortela, E Forsblom, et al.
Pageof 3